← SynDRA
INDOMETHACIN MORPHOLINYLAMIDE
SynDRA canonical compound SYN0003159 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CNR2 |
|---|
| Mechanism of action | Cannabinoid receptor inverse agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Cannabinoid receptor inverse agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- APEX1
- HDAC6
- TDP1
- PTGS2
- PMP22
- PKM
- NFKB1
- MPHOSPH8
- KCNH2
- GMNN
- BLM
- EHMT2
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- CNR1
- TSHR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- BML-190
- BML190
- RefChem:923423
- C23H23ClN2O4
- MFCD01317813
- SR-01000075946
- Bio2_000763
- Tocris-1383
- Lopac-I-151
- Indomethacin morpholinamide
- CBiol_001726
- Lopac0_000685
- BSPBio_001563
- KBioGR_000283
- KBioSS_000283
- BML2-C04
- orb1300787
- SCHEMBL8314320
- SCHEMBL29358919
- CHEBI:93649
- KBio2_000283
- KBio2_002851
- KBio2_005419
- KBio3_000565
- KBio3_000566
- BJSDNVVWJYDOLK-UHFFFAOYSA-N
- Bio1_000012
- Bio1_000501
- Bio1_000990
- Bio2_000283
- HMS1361O05
- HMS1791O05
- HMS1989O05
- HMS3267D16
- HMS3402O05
- HMS3412K16
- HMS3649M07
- HMS3651P17
Look up INDOMETHACIN MORPHOLINYLAMIDE in the interactive SynDRA portal →